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A 2-year-old, mixed breed female dog (16 kg) underwent an exploratory laparotomy 
following ultrasonographic diagnosis of foreign body and a segment of small 
intestine intussusceptions. The patient was classified as an ASA II. Ketamine 
(1mg/kg, IV), and dexmedetomidine (2.5 µg/kg, IV), and morphine (0.6 mg/kg, SC) 
were given as anesthetic premedication. Propofol (0.1 mg/kg, IV) titrated to a total 
amount of 4 ml (2.5 mg/ kg) was given for intubation. Asystole was occurred. 
Cardiac resuscitation was then conducted immediately. Atipamezole (0.1 ml) was 
injected, but showed no response on ECG. Atropine (0.02 mg/kg) was then injected, 
and a second dosage was given. Two-three mins later, the heart rate at 84 beats/min. 
The NIBP showed 203/132 with MAP 153 mmHg, and the SpO2 showed 95% after 
the cardiac function was regained. Dexmedetomidine related bradycardia leading to 
cardiac arrest has been suggested in this case. 
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INTRODUCTION 
 
Dexmedetomidine is widely used in various clinical 
indications including anxiolytic, analgesia, and sedation 
that reflect them suitable as adjuncts in anesthesia. One of 
the benefits in using dexmedetomidine is that it causes 
minimum respiratory effect (Gerlach and Dasta, 2007). 
However, the common adverse reactions associated with 
dexmedetomidine in a Phase III study in 401 patients were 
hypotension (30%), hypertension (12%), nausea (11%), 
bradycardia (9%), and dry mouth (3%) (Bhana et al., 
2000). Among all the adverse effects, hypotension 
(22.7%) and bradycardia (4.4%) were the most commonly 
reported in a dexmedetomidine registry (Dasta et al., 
2004). The ISO-sparing effect of dexmedetomidine has 
been proven in canine as well as feline patients. A study 
in feline patients using dexmedetomidine from different 
routes (constant rate infusion or epidural) showed that 
dexmedetomidine could reduce isoflurane MAC (Souza et 
al., 2010). Herewith, we presented a case with linear 
foreign body and discussed the possible causes of cardiac 
arrest during anesthesia. 
 
HISTORY 
 
A 2-year-old, crossbred female dog (16 kg) was 
admitted to the Veterinary Medicine Teaching Hospital of 
National Chung Hsing University for the treatment of 5-
day standing vomiting and defecation with fabric specks. 
The patient’s vaccination record was current, had no 
history of allergic reaction(s) to any mediations or foods, 
and no previous anesthesia record was available. 
During the initial physical examination, the mucosal 
membranes were normal (pink and moist), and the 
capillary refill time was <2 seconds. The body condition 
score was 4/9. The rectal temperature was 38.3°C. The 
dog was panting with the pulse rate at 100 beats/min. 
Distended bowls were noted in palpation. Blood 
examination revealed leukocytosis (30,300/µl; reference 
range, 6,000-18,000/µl) with left shift (3030/µl; reference 
range, 0-450/µl). Serum electrolytes analysis revealed 
hyponatremia (123 mmol/L; reference range, 140-155 
mmol/L), hypokalemia (3.0 mmol/L; reference range, 3.6-
5.8 mmol/L) and hypochloremia (73 mmol/L; reference 
range, 96-124 mmol/L).  
A dilated plicated loop containing a few round gas 
shapes at the right side of abdomen was observed by 
abdominal radiology and a linear foreign body was 
suspected. Ultrasound examination found the linear 
foreign body and a segment of jejunal intussusception. 
An exploratory laparotomy for removal of the linear 
foreign body was planned. Prophylactic antibiotics such 
as ampicillin and metronidazole were administered to the 
patient. The patient was classified as an ASA II patient 
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(patient with mild systemic disease). Ketamine (1mg/kg, 
IV) and dexmedetomidine (2.5 µ/kg, IV), and 
subcutaneous morphine (0.6 mg/kg, SC) were given as 
anesthetic premedication. Propofol (0.1 mg/kg, IV) 
titrated to a total amount of 4 ml (2.5 mg/ kg) was given 
for intubation. A 9.5-mm cuffed endotracheal tube was 
placed in the trachea. The anesthesia was maintained 
using isoflurane in oxygen (flow rate, 0.5L/min). When 
the end-tidal concentration of isoflurane gradually 
increased to 0.5%, the heart rate was decreased from 149 
to 79 beats/min and the ECG showed sinus arrhythmia. 
Ten minutes later, the heart rate decreased dramatically to 
29 bpm and the SpO2 dropped to 83%. An asystole then 
occurred. At the time of cardiac arrest, the isoflurane 
concentration was 1.2% with oxygen. Cardiac 
resuscitation was then conducted immediately. Isoflurane 
was turned off and 100% oxygen was given (2L/ min) 
until extubation. Atipamezole (0.1 ml) was injected 
through intravenous catheter, but the patient still showed 
no electronic cardiac response on ECG monitor. Atropine 
(0.02 mg/kg) was then injected intravenously, and a 
second dosage was given subcutaneously. The patient was 
resuscitated with the heart rate at 84 beats/min 2-3 
minutes later. The NIBP showed 203/132 with MAP 153 
mmHg, and the SpO2 showed 95% after the cardiac 
function was regained.  
 
DISCUSSION 
 
Several cases have been reported that dexmedeto-
midine is potential to cause cardiac arrest in human 
patients (Gerlach et al., 2009; Gerlach and Murphy, 2009) 
that have been discussed in several aspects. Firstly, the 
correlation between the cardiac arrest and the decrease 
cardiac output or the myocardial infarction associated 
with dexmedetomidine has been mentioned. In the latter 
report, the possibility that in certain genetically 
predisposed individuals, stimulation of α2-
adrenoreceptors by dexmedetomidine may cause profound 
myocardial ischemia and myocardial dysfunction due to 
coronary vasoconstriction. Secondly, the combination of 
multiple drugs may also augment the bradycardia (Zhang 
et al., 2010). Opioids are also potent stimulants of vagal 
tone through the inhibition of sympathetic outflow, and 
this action may combine with dexmedetomidine to result 
in hypotension and bradycardia. Propofol administration 
should also be considered another potential cause of 
bradycardia. Propofol can cause bradycardia through β-2 
adrenergic receptors block or through M-2 acetylcholine 
receptor activation. However, the clinical occurrence of 
bradycardia with propofol (in the absence of concomitant 
opioid administration) has been reported only in 
preexisting myocardial depression or as a part of the 
propofol infusion syndrome (PRIS). In the present case, 
the patient had received the combination of morphine and 
dexmedetomidine, following propofol for the induction. 
The cardiac arrest occurred shortly after intubation 
procedure which could stimulate the vagal tone activity 
and then worsen the bradycardia, leading to the cardiac 
arrest. 
The mechanism of sedative effect of dexmedeto-
midine takes place in the brain called locus ceruleus, in 
which dexmedetomidine stimulates alpha 2 receptors on 
the presynaptic neurons. The activation of the alpha 2 
adrenergic receptor will then inhibit adenyl cyclase. 
Following a complex cascade, an efﬂux of potassium 
through calcium-activated potassium channels and an 
inhibition of calcium into calcium channels in nerve 
terminals then occur. The change in membrane ion 
conductance leads to a hyperpolarization of the 
membrane, which suppresses neuronal ﬁring in the locus 
ceruleus as well as its activity in the ascending 
noradrenergic pathway. To sum up, the net effect is 
decreased in norepinephrine release from presynaptic 
neurons with inhibition of postsynaptic activation, which 
attenuates central nervous system excitation. Additionally, 
the ISO-sparing effect of dexmedetomidine has been 
proven both in canine (Uilenreef et al., 2008) and feline 
(Souza et al., 2010) patients. Epidural dexmedetomidine 3 
µg/ kg in dogs reduced isoﬂurane MAC by 29 %. In cats, 
a slight increase in epidural dexmedetomidine dose (4 µg/ 
kg) reduced 47% requirement of isoﬂurane, suggesting 
that a small increase in epidural dexmedetomidine dose 
resulted in a larger sparing effect in cats under isoﬂurane 
anesthesia, or that dexmedetomidine might have a greater 
effect in cats than in dogs. In the present case, the cardiac 
arrest occurred when the isoflurane reached to the highest 
level. Due to the sparing effect and isoflurane, the 
increasing isoflurane concentration might be one of the 
reasons that led to cardiac arrest.  
It is concluded that the present case of cardiac arrest 
was associated with dexmedetomidine premedication to 
supplement isoflurane general anesthesia and a prompt 
cardiac resuscitation resulted in complete recovery. It 
appears that combined anesthetic factors led to severe 
bradycardia and cardiac arrest and a care must be taken 
while using dexmedetomidine as premedication for 
isoflurane anesthesia in dogs. 
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